|
HY-P701103-10ug
|
MedChemexpress LLC
|
MSP/MST1, Mouse (C677A, HEK293)
|
|
|
|
|
HY-P701103-5ug
|
MedChemexpress LLC
|
MSP/MST1, Mouse (C677A, HEK293)
|
|
|
|
|
HY-P701103-50ug
|
MedChemexpress LLC
|
MSP/MST1, Mouse (C677A, HEK293)
|
|
|
|
|
HY-P72077-10ug
|
MedChemexpress LLC
|
Mu ellerian-inhibiting factor/AMH, Mouse
|
|
|
|
|
HY-P72077-5ug
|
MedChemexpress LLC
|
Mu ellerian-inhibiting factor/AMH, Mouse
|
|
|
|
|
HY-P72077-50ug
|
MedChemexpress LLC
|
Mu ellerian-inhibiting factor/AMH, Mouse
|
|
|
|
|
HY-P73239-60U
|
MedChemexpress LLC
|
NA/Neuraminidase, Influenza A H5N1 (H255Y, HEK293)
|
|
|
|
|
HY-P73307-10ug
|
MedChemexpress LLC
|
Nectin-2/CD112, Human (HEK293)
|
|
|
|
|
HY-P73307-100ug
|
MedChemexpress LLC
|
Nectin-2/CD112, Human (HEK293)
|
|
|
|
|
HY-P73307-5ug
|
MedChemexpress LLC
|
Nectin-2/CD112, Human (HEK293)
|
|
|
|
|
HY-P73307-50ug
|
MedChemexpress LLC
|
Nectin-2/CD112, Human (HEK293)
|
|
|
|
|
HY-P70843-10ug
|
MedChemexpress LLC
|
NEDD8, Human
|
|
|
|
|
HY-P70843-50ug
|
MedChemexpress LLC
|
NEDD8, Human
|
|
|
|
|
HY-B0497S1-10mg
|
MedChemexpress LLC
|
Niclosamide-13C6 [CAS 1325808-64-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0497S1-5mg
|
MedChemexpress LLC
|
Niclosamide-13C6 [CAS 1325808-64-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-139192A-10mg
|
MedChemexpress LLC
|
NMDAR/TRPM4-IN-2 (free base) [CAS 1353979-43-7]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-139192A-100mg
|
MedChemexpress LLC
|
NMDAR/TRPM4-IN-2 (free base) [CAS 1353979-43-7]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-139192A-5mg
|
MedChemexpress LLC
|
NMDAR/TRPM4-IN-2 (free base) [CAS 1353979-43-7]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-139192A-50mg
|
MedChemexpress LLC
|
NMDAR/TRPM4-IN-2 (free base) [CAS 1353979-43-7]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-139192A-1mL
|
MedChemexpress LLC
|
NMDAR/TRPM4-IN-2 (free base) [CAS 1353979-43-7] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-114503-10mg
|
MedChemexpress LLC
|
NSAH [CAS 1099592-35-4]
|
|
Cancer-programmed cell death
|
|
|
HY-114503-100mg
|
MedChemexpress LLC
|
NSAH [CAS 1099592-35-4]
|
|
Cancer-programmed cell death
|
|
|
HY-114503-25mg
|
MedChemexpress LLC
|
NSAH [CAS 1099592-35-4]
|
|
Cancer-programmed cell death
|
|
|
HY-114503-5mg
|
MedChemexpress LLC
|
NSAH [CAS 1099592-35-4]
|
|
Cancer-programmed cell death
|
|
|
HY-114503-50mg
|
MedChemexpress LLC
|
NSAH [CAS 1099592-35-4]
|
|
Cancer-programmed cell death
|
|
